Buy Replimune Group Inc Stock | REPL Stock Price & Latest News | Public.com
REPL

Replimune Group Inc

$0.00 (0.00%)Today
    View Replimune Group Inc (REPL) stock trends here

    About REPL

    Replimune Group, Inc. is a clinical-stage biotechnology company, which engages in the development of oncolytic immunotherapy product candidates through immulytic platform. Oncolytic immunotherapy is a cancer treatment that exploits the ability of certain viruses to sele...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.15
    -0.31
    -0.46
    Q3 2020
    Q4 2020
    Q1 2021
    Q2 2021

    Expected EPS
    Q2 2021

    -$0.45

    Actual EPS
    Q2 2021

    Stats

    Market Cap$1,68B
    Volume102,82k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$54.85
    1 Year Low$8.58
    Open$35.87
    High$36.73
    Low$35.25

    Buy any stock with any amount of money.

    Download the App
    Download the app